ABSI
Absci CorporationNASDAQHealthcare$3.06-2.86%ClosedMarket Cap: $468.2M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
2.43
P/S
167.23
EV/EBITDA
-4.01
DCF Value
$0.04
FCF Yield
-20.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
-1316.1%
Operating Margin
-4479.2%
Net Margin
-4113.7%
ROE
-59.7%
ROA
-65.9%
ROIC
-63.9%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $650.0K | -335.1% | $-36.1M | $-29.6M | $-0.20 | — |
| FY 2025 | $2.8M | -319.4% | $-124.7M | $-115.2M | $-0.84 | — |
| Q3 2025 | $378.0K | 100.0% | $-30.2M | $-28.7M | $-0.20 | — |
| Q2 2025 | $593.0K | -3349.9% | $-31.4M | $-30.6M | $-0.24 | — |
| Q1 2025 | $1.2M | -1288.0% | $-27.7M | $-26.3M | $-0.21 | — |
| Q4 2024 | $665.0K | -2452.9% | $-29.8M | $-29.0M | $-0.25 | — |
| FY 2024 | $4.5M | -1277.6% | $-108.9M | $-103.1M | $-0.94 | — |
| Q3 2024 | $1.7M | -97.2% | $-28.9M | $-27.4M | $-0.24 | — |
| Q2 2024 | $1.3M | -1101.7% | $-26.7M | $-24.8M | $-0.22 | — |
| Q1 2024 | $898.0K | -1262.6% | $-23.5M | $-22.0M | $-0.22 | — |
| Q4 2023 | $338.0K | -3382.0% | $-24.7M | $-23.5M | $-0.25 | — |
| FY 2023 | $5.7M | -731.9% | $-115.5M | $-110.6M | $-1.20 | — |